Benign Disease of Uterus

Embed Size (px)

Citation preview

  • 7/30/2019 Benign Disease of Uterus

    1/22

    Benign Disease of Uterus

  • 7/30/2019 Benign Disease of Uterus

    2/22

    Classified in termsof the tissue origin

    Uterine cervix

    Endometrium

    Myometrium

    Cervical ectropion

    Cervical stenosis

    Endometrium polyp

    Asherman syndrome

    Uterine fibroid

  • 7/30/2019 Benign Disease of Uterus

    3/22

    Anatomy of cervix

    This anatomicaljunction fluctuates

    with hormonalinfluence

  • 7/30/2019 Benign Disease of Uterus

    4/22

    Origin: Uterine cervix

  • 7/30/2019 Benign Disease of Uterus

    5/22

  • 7/30/2019 Benign Disease of Uterus

    6/22

    - An infection screen to exclude chlamydia & other STI should be

    performed prior to tx

    *Nabothian cyst: The columnar glands within the transformation zone become sealedover, forming small, mucus filled cysts (visible on ectocervix)

  • 7/30/2019 Benign Disease of Uterus

    7/22

    Cervical Stenosis

    Usually an iatrogenic phenomena caused bya surgical event (cone biopsy, loopdiathermy)

    T(x): Surgical dilatation of the cervix withhysteroscopic guidance

  • 7/30/2019 Benign Disease of Uterus

    8/22

    Cervical Stenosis

  • 7/30/2019 Benign Disease of Uterus

    9/22

    Origin: Endometrium

  • 7/30/2019 Benign Disease of Uterus

    10/22

    Endometrial Polyps

    What?

    Discreteoutgrowth

    ofendometrium, attachedby a pedicle

    -pedunculated/

    sessile

    -single/multiple-vary in size

    Vaginalbleeding

    Mucus

    discharge

    S & S Diagnosis

    Ultrasound:Areas of

    increasedendometrial

    thickening

    Sonohysterography: Confirmsthe diagnosis

    Postmenopausal

    age

    Mandatory to remove EP, whichcan be due to hyperplasia or

    malignancy

    >40 y/o &premenopausal

    Removal: Usually resolves thesymptoms

    Most common abnormality:endometrial hyperplasia

    EP should be considered for removal

  • 7/30/2019 Benign Disease of Uterus

    11/22

    Asherman SyndromeCauses:

    Overzealous curettage of theuterine cavity during D&C/following 2 PPH

    TB, schistosomiasis

    T(x): Difficult to treat; prevention is

    the mainstay of therapy

    Option: Hysteroscopic techniqueto manually break down or lysed

    intrauterine adhesion

    An irreversible damage of the single layerthick basal endometrium

    Doesnt allow normal regeneration of

    the endometrium

    Endometrial cavity undergoes fibrosis &adhesion formation

    Ashermansyndrome

    Reduced / absent

    menstrual bleeding

  • 7/30/2019 Benign Disease of Uterus

    12/22

  • 7/30/2019 Benign Disease of Uterus

    13/22

    Origin: Myometrium

  • 7/30/2019 Benign Disease of Uterus

    14/22

    Uterine Fibroids

    DefinitionA benign tumour of uterine smooth muscle

    Termed as leiomyoma

    Pathology Firm, whorled tumour

    Typical whorled appearancemay be altered from

    following degenerations:

    Red degeneration

    Hyaline degeneration

    Cystic degeneration

    Unknown, but an estrogen dependant tumourEtiology & RF

    Nulliparity, obesity, (+) family h(x), African racial origin

    Incidence 20% in reproductive age

    Based on the location

    Submucous fibroid

    Intramural fibroid

    Subserosal fibroid

    Pedunculated

  • 7/30/2019 Benign Disease of Uterus

    15/22

    Location of Fibroids

  • 7/30/2019 Benign Disease of Uterus

    16/22

    Clinical subgroups

  • 7/30/2019 Benign Disease of Uterus

    17/22

  • 7/30/2019 Benign Disease of Uterus

    18/22

    Signs &symptoms

    History

    Usually asymptomatic

    Menstrual disturbance &pressure symptoms

    Pain: unsual

    Menorrhagia

    Indicates submucousorigin

    Distorting the endometrialcavity by increasing theendometrial surface area

    Subfertility

    Mechanical distortion

    / occlusion of FT

    Endometrial cavity grosslydistorted by submucous

    fibroid; prevent implantationof a fertilized ovum

    Abdominalexamination

    Presence of firm

    mass arisingfrom the pelvic

    In late pregnancy:abnormal lie (fibroidlocated in the cervix /

    lower uterine segment)

  • 7/30/2019 Benign Disease of Uterus

    19/22

    Fibroid Degeneration

    Red Degeneration

    An acute disruption of theblood supply to the fibroidduring active growth,classically during mid-second

    trimester of pregnancy May present with the sudden

    onset of pain with localizedtenderness to an area ofuterus, mild pyrexia,leuckocytosis

    Sign and symptoms resolve

    over a few days Surgical intervention rarely

    required

    Hyalin Degeneration

    Occurs when the fibroidgradually outgrows its bloodsupply, may progress tocentral necrosis, leaving

    cystic space at central

    termed cystic degeneration

    Calcification of a fibroid maybe detected incidentally on anabdominal x-ray in a post-menopause woman

    Rarely, malignant or

    sarcomatous degenerationcan occur

    The suspicion is greatest inthe post-menopausal periodwhen there is a rapidlyincreasing size of fibroid

  • 7/30/2019 Benign Disease of Uterus

    20/22

    Diagnosis & Investigation

    From generalexamination : reveal

    varying degree of anemia

    Palpation : palpablemass, firm, well-defined

    margin,

    Bimanual examination :uterus enlarged

    Ultrasound will confirmthe diagnosis

    Diagnostic laparoscopyhelpful to differentiate apedunculated subserous

    fibroid from a solidovarian tumor

    Hysterosalphingographyor hysteroscopy will help

    to detect submucousfibroid

    Hysteroscopy and endometrial biopsy isindicated in cases of irregular or

    intermenstrual bleeding to exclude thepresence of coexisting endometrial pathology

  • 7/30/2019 Benign Disease of Uterus

    21/22

    Conservativemanagement

    Asymptomatic

    fibroidsIt is useful to establishthe growth rate of the

    fibroids by repeatclinical examination orultrasound after a 6-12

    month interval.

    Medical t(x)

    Gonadotrophin

    releasing hormone(GnRH) agonists. Usually limited touse in preparation

    for surgery

    Surgical t(x)

    Determined by thepresenting complaint & pts

    aspirations for menstrualfunction & fertility

    Hysteroscopic removal:Menorrhagia associated with

    a submucous fibroidMyomectomy w uterine

    conservation @hysterectomy: Bulky fibroiduterus causes pressure

    symptoms

    Treatment

  • 7/30/2019 Benign Disease of Uterus

    22/22Thank You